This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Ramana Doppalapudi, PhD
Vice President, Chemistry at Avidity Biosciences
Speaker

Profile

Dr. Ramana Doppalapudi is a seasoned scientist with broad expertise in the discovery and development of diverse therapeutic modalities, including peptides, antibodies, oligonucleotides, and antibody-drug conjugates. He has a strong track record of leadership across pharmaceutical companies of various sizes, consistently driving innovation and advancing multiple clinical candidates for the treatment of cancer, and muscular diseases. He is a key inventor of the pioneering AOCTM (Antibody Oligonucleotide Conjugate) technology and has a pivotal role in the advancement of notable drug candidates such as Del-desiran, Del-brax, and Del-zota. He is the author of more than 50 scientific publications and patents and currently serves as Vice President of Chemistry at Avidity Biosciences in La Jolla, California.


Agenda Sessions

  • Advancing Therapeutics with Antibody-Oligonucleotide Conjugates: Clinical Progress in Rare Muscle Diseases and Emerging Applications in Precision Cardiology

    9:30am